We are a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer. Utilizing our proprietary phosphoramidate technology we are developing more effective and safer anti-cancer medicines. 

NuCana is led by a highly experienced management team with extensive drug development & commercialization expertise.